Pearl River Capital, LLC Qiagen N.V. Transaction History

Pearl River Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$41.91 - $50.48 $474,840 - $571,938	11,330 Added 191.81%	17,237 $859,000
Q3 2022 Nov 14, 2022	SELL	$40.9 - $50.42 $137,055 - $168,957	-3,351 Reduced 36.2%	5,907 $244,000
Q2 2022 Aug 12, 2022	SELL	$42.98 - $49.77 $48,395 - $56,041	-1,126 Reduced 10.84%	9,258 $437,000
Q1 2022 May 13, 2022	BUY	$42.23 - $54.3 $192,864 - $247,988	4,567 Added 78.51%	10,384 $509,000
Q4 2021 Feb 11, 2022	BUY	$50.62 - $56.47 $294,456 - $328,485	5,817 New	5,817 $323,000
Q4 2019 Feb 12, 2020	SELL	$25.41 - $43.1 $8,690 - $14,740	-342 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$32.73 - $40.81 $11,193 - $13,957	342 New	342 $11,000

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.5B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.